Business · 10/02/2003Updated: 10/17/2026 · 1 min read
FDA Requests Public Comment on Proposed Collection of Medical Products Reporting Program Information
Summary
The Food and Drug Administration is seeking public input on the proposed collection of information for its MedWatch program, which tracks adverse events related to FDA-regulated products, and must publish the notice in the Federal Register for 60 days of public comment.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →